Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alexar formed by NeXeption; raises $21.5mm through its Series A round

Executive Summary

Biopharma management company NeXeption LLC formed Alexar Therapeutics Inc. (dermatology compounds) in conjunction with a $21.5mm Series A venture round. New Science Ventures and Third Point Ventures led (and each contribute one board member) and were joined by Palo Alto Investors.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies